Sign in

CIK 0001326732 · Accelerated filer

Ticker
XNCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
201622502
Phone
626-305-5900
Business address
465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,591,617
in 2 filings

Net −$3,591,617. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-03 Dahiyat Bassil I PRESIDENT & CEO Option exercise +8,808 $15.69 $138K 375,390
2025-02-03 Dahiyat Bassil I PRESIDENT & CEO Option exercise · Stock Option (Right to Buy) −8,808 0
2024-12-04 Montgomery Alan Bruce Director Option exercise 10b5-1 +991 $15.35 $15K 10,131
2024-12-04 Montgomery Alan Bruce Director Option exercise 10b5-1 +430 $20.00 $9K 10,561
2024-12-04 Montgomery Alan Bruce Director Sale 10b5-1 −1,421 $27.03 $38K 9,140
2024-12-04 Montgomery Alan Bruce Director Option exercise · Stock Option (Right to Buy) 10b5-1 −991 5,716
2024-12-04 Montgomery Alan Bruce Director Option exercise · Stock Option (Right to Buy) 10b5-1 −430 2,062
2024-12-02 Montgomery Alan Bruce Director Option exercise 10b5-1 +8,293 $15.35 $127K 17,433
2024-12-02 Montgomery Alan Bruce Director Option exercise 10b5-1 +5,008 $20.00 $100K 22,441
2024-12-02 Montgomery Alan Bruce Director Sale 10b5-1 −13,301 $27.03 $360K 9,140
2024-12-02 Montgomery Alan Bruce Director Option exercise · Stock Option (Right to Buy) 10b5-1 −5,008 2,492
2024-12-02 Montgomery Alan Bruce Director Option exercise · Stock Option (Right to Buy) 10b5-1 −8,293 6,707
2024-11-22 Dahiyat Bassil I PRESIDENT & CEO Option exercise 10b5-1 +13,548 $15.69 $213K 366,163
2024-11-22 Dahiyat Bassil I PRESIDENT & CEO Option exercise · Stock Option (Right to Buy) 10b5-1 −13,548 8,808
2024-11-21 Dahiyat Bassil I PRESIDENT & CEO Option exercise 10b5-1 +49,278 $15.69 $773K 401,893
2024-11-21 Dahiyat Bassil I PRESIDENT & CEO Sale 10b5-1 −49,278 $24.07 $1.2M 352,615
2024-11-21 Dahiyat Bassil I PRESIDENT & CEO Option exercise · Stock Option (Right to Buy) 10b5-1 −49,278 22,356
2024-11-13 Dahiyat Bassil I PRESIDENT & CEO Option exercise 10b5-1 +3,366 $15.69 $53K 355,981
2024-11-13 Dahiyat Bassil I PRESIDENT & CEO Sale 10b5-1 −3,366 $24.02 $81K 352,615
2024-11-13 Dahiyat Bassil I PRESIDENT & CEO Option exercise · Stock Option (Right to Buy) 10b5-1 −3,366 71,634

Page 6 of 11 · 211 trades